WordNet

a substance that partly or completely destroys animal cells
a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
how long something has existed; "it was replaced because of its age"
a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
begin to seem older; get older; "The death of his wife caused him to age fast"
make older; "The death of his child aged him tremendously"
of or relating to substances that are toxic to cells

PrepTutorEJDIC

『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/07/29 12:52:20」(JST)

wiki en

Cytotoxicity is the quality of being toxic to cells. Examples of toxic agents are an immune cell or some types of venom, e.g. from the puff adder (Bitis arietans) or brown recluse spider (Loxosceles reclusa).

Cell physiology

Treating cells with the cytotoxic compound can result in a variety of cell fates. The cells may undergo necrosis, in which they lose membrane integrity and die rapidly as a result of cell lysis. The cells can stop actively growing and dividing (a decrease in cell viability), or the cells can activate a genetic program of controlled cell death (apoptosis).

Cells undergoing necrosis typically exhibit rapid swelling, lose membrane integrity, shut down metabolism and release their contents into the environment. Cells that undergo rapid necrosis in vitro do not have sufficient time or energy to activate apoptotic machinery and will not express apoptotic markers.^[1] Apoptosis is characterized by well defined cytological and molecular events including a change in the refractive index of the cell, cytoplasmic shrinkage, nuclear condensation and cleavage of DNA into regularly sized fragments.^[2] Cells in culture that are undergoing apoptosis eventually undergo secondary necrosis. They will shut down metabolism, lose membrane integrity and lyse.^[2]^[3]

Measuring cytotoxicity

Cytotoxicity assays are widely used by the pharmaceutical industry to screen for cytotoxicity in compound libraries. Researchers can either look for cytotoxic compounds, if they are interested in developing a therapeutic that targets rapidly dividing cancer cells, for instance; or they can screen "hits" from initial high-throughput drug screens for unwanted cytotoxic effects before investing in their development as a pharmaceutical.

Assessing cell membrane integrity is one of the most common ways to measure cell viability and cytotoxic effects. Compounds that have cytotoxic effects often compromise cell membrane integrity. Vital dyes, such as trypan blue or propidium iodide are normally excluded from the inside of healthy cells; however, if the cell membrane has been compromised, they freely cross the membrane and stain intracellular components.^[3] Alternatively, membrane integrity can be assessed by monitoring the passage of substances that are normally sequestered inside cells to the outside. One molecule, lactate dehydrogenase (LDH), is commonly measured using LDH assay.^[4] Protease biomarkers have been identified that allow researchers to measure relative numbers of live and dead cells within the same cell population. The live-cell protease is only active in cells that have a healthy cell membrane, and loses activity once the cell is compromised and the protease is exposed to the external environment. The dead-cell protease cannot cross the cell membrane, and can only be measured in culture media after cells have lost their membrane integrity.^[5]

Cytotoxicity can also be monitored using the 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) or MTS assay. This assay measures the reducing potential of the cell using a colorimetric reaction. Viable cells will reduce the MTS reagent to a colored formazan product. A similar redox-based assay has also been developed using the fluorescent dye, resazurin. In addition to using dyes to indicate the redox potential of cells in order to monitor their viability, researchers have developed assays that use ATP content as a marker of viability.^[3] Such ATP-based assays include bioluminescent assays in which ATP is the limiting reagent for the luciferase reaction.^[6]

Cytotoxicity can also be measured by the sulforhodamine B (SRB) assay, WST assay and clonogenic assay.

A label-free approach to follow the cytotoxic response of adherent animal cells in real-time is based on electric impedance measurements when the cells are grown on gold-film electrodes. This technology is referred to as electric cell-substrate impedance sensing (ECIS). Label-free real-time techniques provide the kinetics of the cytotoxic response rather than just a snapshot like many colorimetric endpoint assays.

Predicting cytotoxicity

A highly important topic is the prediction of cytotoxicity of chemical compounds based on previous measurements, i.e. in-silico testing.^[7] For this purpose many QSAR and virtual screening methods have been suggested. An independent comparison of these methods has been done within the "Toxicology in the 21st century" project.^[8] In this comparison Deep Learning has shown the highest performance at the prediction of cytotoxic effects.^[9]^[10]^[11]

Cytotoxicity in cancer

Chemotherapy as a treatment of cancer often relies on the ability of these agents to kill or damage cells which are reproducing; this preferentially targets rapidly dividing cancer cells.^[12]

Immune system cytotoxicity

Antibody-dependent cell-mediated cytotoxicity (ADCC) describes the cell-killing ability of certain lymphocytes, which requires the target cell being marked by an antibody. Lymphocyte-mediated cytotoxicity, on the other hand, does not have to be mediated by antibodies; nor does complement-dependent cytotoxicity (CDC), which is mediated by the complement system.

Three groups of cytotoxic lymphocytes are distinguished:

Cytotoxic T cells
Natural killer cells
Natural killer T cells

References

^ Promega Corporation (2006) Protocols and Applications Guide. Cell Viability.
^ ^a ^b Promega Corporation (2007) Protocols and Applications Guide. Apoptosis.
^ ^a ^b ^c Riss TL, Moravec RA; Moravec (February 2004). "Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays". Assay Drug Dev Technol 2 (1): 51–62. doi:10.1089/154065804322966315. PMID 15090210.
^ Decker T, Lohmann-Matthes ML; Lohmann-Matthes (November 1988). "A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity". J. Immunol. Methods 115 (1): 61–9. doi:10.1016/0022-1759(88)90310-9. PMID 3192948.
^ Niles AL, Moravec RA, Eric Hesselberth P, Scurria MA, Daily WJ, Riss TL; Moravec; Eric Hesselberth; Scurria; Daily; Riss (July 2007). "A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers". Anal. Biochem. 366 (2): 197–206. doi:10.1016/j.ab.2007.04.007. PMID 17512890.
^ Fan F, Wood KV; Wood (February 2007). "Bioluminescent assays for high-throughput screening". Assay Drug Dev Technol 5 (1): 127–36. doi:10.1089/adt.2006.053. PMID 17355205.
^ Dearden, J. C. (2003). "In silico prediction of drug toxicity". Journal of computer-aided molecular design 17 (2-4): 119–27. PMID 13677480. edit
^ "Toxicology in the 21st century Data Challenge" https://tripod.nih.gov/tox21/challenge/leaderboard.jsp
^ "NCATS Announces Tox21 Data Challenge Winners" http://www.ncats.nih.gov/news-and-events/features/tox21-challenge-winners.html
^ Unterthiner, T.; Mayr, A.; Klambauer, G.; Steijaert, M.; Ceulemans, H.; Wegner, J. K.; & Hochreiter, S. (2014) "Deep Learning as an Opportunity in Virtual Screening". Workshop on Deep Learning and Representation Learning (NIPS2014).
^ Unterthiner, T.; Mayr, A.; Klambauer, G.; & Hochreiter, S. (2015) "Toxicity Prediction using Deep Learning". ArXiv, 2015.
^ "Chemotherapy Principles" (PDF). American Cancer Society. Retrieved 20 August 2014.

External links

Cytotoxins at the US National Library of Medicine Medical Subject Headings (MeSH)
Cytotoxicity Assays, Promega Corporation

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 転移性黒色腫（メラノーマ）の細胞傷害性化学療法 cytotoxic chemotherapy for metastatic melanoma
2. 進行皮膚黒色腫に対するマネージメントの概要 overview of the management of advanced cutaneous melanoma
3. ドライバー変異が認められない進行非小細胞肺癌の初期マネージメントのための全身療法 systemic therapy for the initial management of advanced non small cell lung cancer without a driver mutation
4. 成人における抗癌剤の投与 dosing of anticancer agents in adults
5. 可逆性後白質脳症症候群 reversible posterior leukoencephalopathy syndrome

English Journal

A novel pH-induced thermosensitive hydrogel composed of carboxymethyl chitosan and poloxamer cross-linked by glutaraldehyde for ophthalmic drug delivery.

Yu S1, Zhang X1, Tan G1, Tian L1, Liu D2, Liu Y1, Yang X3, Pan W4.
Carbohydrate polymers.Carbohydr Polym.2017 Jan 2;155:208-217. doi: 10.1016/j.carbpol.2016.08.073. Epub 2016 Aug 25.
In this work, a stimuli-responsive three dimensional cross-linked hydrogel system containing carboxymethyl chitosan (CMC) and poloxamer composed of a poly (ethylene oxide)/poly (propylene oxide)/poly (ethylene oxide) (PEO-PPO-PEO) block copolymer was constructed, and its aqueous solution was found t
PMID 27702506

Synthesis of new thieno[2,3-b]pyridine derivatives as pim-1 inhibitors.

Naguib BH1,2, El-Nassan HB2.
Journal of enzyme inhibition and medicinal chemistry.J Enzyme Inhib Med Chem.2016 Dec;31(6):1718-25. doi: 10.3109/14756366.2016.1158711. Epub 2016 Mar 22.
Three series of 5-bromo-thieno[2,3-b]pyridines bearing amide or benzoyl groups at position 2 were prepared as pim-1 inhibitors. All the prepared compounds were tested for their pim-1 enzyme inhibitory activity. Two compounds (3c and 5b) showed moderate pim-1 inhibitory activity with IC50 of 35.7 and
PMID 27541740

Functionalization of Carbon Nanomaterial Surface by Doxorubicin and Antibodies to Tumor Markers.

Perepelytsina OM1, Yakymchuk OM2, Sydorenko MV1, Bakalinska ON3, Bloisi F4,5, Vicari LR4,5.
Nanoscale research letters.Nanoscale Res Lett.2016 Dec;11(1):314. doi: 10.1186/s11671-016-1537-z. Epub 2016 Jun 29.
The actual task of oncology is effective treatment of cancer while causing a minimum harm to the patient. The appearance of polymer nanomaterials and technologies launched new applications and approaches of delivery and release of anticancer drugs. The goal of work was to test ultra dispersed diamon
PMID 27356561